Eris Lifesciences Limited (NSE:ERIS)
1,551.70
-8.20 (-0.53%)
At close: Dec 5, 2025
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 211.37 billion as of December 5, 2025. Its market cap has increased by 14.75% in one year.
Market Cap
211.37B
Enterprise Value
238.63B
Revenue
29.86B
Ranking
n/a
PE Ratio
50.95
Stock Price
1,551.70
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 211.37B, an increase of 155.56%. That is a compound annual growth rate of 11.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,331.52B |
| Divi's Laboratories | 1,718.51B |
| Cipla | 1,228.46B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |